GCTK 2.17 GlucoTrack, Inc.
| Range: | 0.665-4.95 | Vol Avg: | 16148 | Last Div: | 0 | Changes: | 0.05 |
| Beta: | 0.13 | Cap: | 0.01B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Thu Apr 25 2013 | Empoloyees: | 6 | ||
| CUSIP: | 45824Q507 | CIK: | 0001506983 | ISIN: | US45824Q5071 | Country: | IL |
| CEO: | Mr. Paul V. Goode Ph.D. | Website: | https://www.glucotrack.com | ||||
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow